Have Any Questions?

 

Milestones

1991    – Started as Intermed Pharma to manufacture of intermediates to APIs.

 

2001    – Unit-2 was commissioned to manufacture advanced intermediates.

 

2006    – Commenced manufacturing of Capecitabine (Oncology APIs).

 

2007    – Commenced manufacturing of First General APIs (Efavirenz).

 

2009    – Company name changed as Cdymax (India) Pharma Pvt. Ltd.

 

2011    – New Production Block  (PB-2) commissioned  to manufacture of  Oncology APIs and

…………started manufacturing  from July 2011.

 

2012    – Company name changed as Acebright (India) Pharma Pvt. Ltd., in April 2012.

 

2012   – Production Block (PB-1) renovated for manufacturing of General APIs.

 

2013   – WHO Geneva Approval.